BIO Middle East 2026

Monday, December 14, 2026

BIO Middle East 2026

Biotech partnering event and exhibition linking pharma, startups, investors and regulators in Saudi Arabia and the region.

Date and Time

December 14 · 9am - December 16 · 6pm GMT+3

Location

Riyadh Exhibition & Convention Centre (Malham)

Al Qassim Road, Malham Riyadh Province 13380

About This Event

BIO Middle East 2026 is a Healthcare event taking place 14-16 Dec 2026 at Riyadh Exhibition & Convention Centre (Malham), Riyadh, Saudi Arabia.

BIO Middle East is the region's biotechnology and life sciences platform for partnering, business matchmaking and public-private collaboration, organised by Tahaluf and supported by the Saudi Ministry of Health. Co-located with CPHI Middle East in Riyadh, it uses the partneringONE® system to set up curated one-to-one meetings for licensing, partnerships and investment deals, alongside an agenda on cell and gene therapies, mRNA, next-generation vaccines and biomanufacturing.

Who attends

The event aims to cover the whole biotech value chain, from research to deployment.

  • Pharma and biopharma companies
  • Biotech startups and SMEs
  • Investors, VCs and accelerators
  • CDMOs and biomanufacturers
  • Vaccine developers
  • Research institutes and hospitals
  • Lab equipment suppliers
  • Regulators and government bodies

Three conference stages

The programme runs across three stages.

  • Main Stage: leadership keynotes and panels on biotech ecosystems and commercialisation
  • Technical Stage: vaccines, mRNA, cell and gene therapies, clinical trials, regulation and GMP
  • Innovation Pitches Stage: startups, SMEs and research centres pitch to investors and pharma business development teams over three days

Partnering and networking

The Biotech Partnering Programme runs on partneringONE®, with pre-scheduled meetings matched through attendee profiles. Curated networking side events and a start-up market round out the format.

Speakers

2026 speakers include HRH Haya Al Saud of the Hevolution Foundation, SPIMACO vice chairman Ahmed Aljedai, Novartis APMA president Judith Love, Alliance for Regenerative Medicine CEO Timothy Hunt, Cell & Gene Therapy Catapult chief executive Matthew Durdy, and leaders from Amgen, Gilead, Bristol Myers Squibb, Johnson & Johnson, CEPI, Gavi, KAUST and KFSHRC.

Co-located with CPHI Middle East

Together, BIO Middle East and CPHI Middle East expect more than 60,000 visitors, 1,000+ exhibiting brands from 100+ countries and 310 speakers, giving access to both the pharma supply chain and the biotech community in one venue.

Tickets & passes

  • Visitor pass — Free: Free entry for registered trade visitors (18+)

Agenda

Main Stage

Global leadership keynotes and panels on biotech ecosystems, scientific breakthroughs and commercialisation

Technical Stage

Vaccines, mRNA, cell & gene therapies and the biotech lifecycle from R&D to clinical trials, with a regulatory and GMP focus

Innovation Pitches Stage

Startups, SMEs and research centres pitch to investors, accelerators and pharma BD teams

Frequently asked questions

About this listing

Details are collected from the organizer’s official site, biomiddleeast.com.

Get Engaged

to post a comment

No comments yet. Be the first to comment!

December 14 · 9am - December 16 · 6pm GMT+3

BIO Middle East 2026